We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Laser System Treats Inflammatory Acne Vulgaris

By HospiMedica staff writers
Posted on 16 Jul 2003
A laser system that can increase collagen production by 99.5% and effectively treat many vascular disorders can also treat inflammatory acne vulgaris. More...
This application has been cleared by the US Food and Drug Administration (FDA).

The system is a fast-pulsed dye laser that emits a wavelength of yellow light directly over problem areas. This heats small blood vessels, allowing them to open and release healing mediators that, in turn, encourage the natural healing process and stimulate collagen production. In a trial at Hammersmith Hospital (London, UK) involving 41 patients, a single five-minute treatment with the laser system resulted in a 50% improvement in acne lesion count. In addition, about 25% of the patients were acne-free after treatment.

"This noninvasive laser targets the skin's small blood vessels, so it does not cut or burn the outermost layer of the epidermis,” said Dr. Suzanne Kilmer, past president of the American Society for Laser Medicine. "Thus, no anesthesia is required. There are no side effects, treatment is pain-free, and the patient has no downtime as a result of this procedure.”

Called NLite-V, the laser system was developed by USA Photonics, Inc. (Nanuet, NY, USA), using the company's Smartpulse technology. The company states that NLite is the first major advance in the field of dermatology in more than 30 years.




Related Links:
USA Photonics

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
X-Ray System
Leonardo DR mini III
Radiology System
Riviera SPV AT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.